Description
MEDICATION FOR PATIENT TREATMENT-RADIOPHARMACEUTICALS
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-07-28+$1,297,232= $1,297,232
- Mod P000012024-08-26+$122,587= $1,419,819
- Mod P000022025-01-29+$4,183= $1,424,002
- Mod P000032026-05-04-$2,789= $1,421,213
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-07-28 | +$1,297,232 | $1,297,232 | MEDICATION FOR PATIENT TREATMENT-RADIOPHARMACEUTICALS |
| Mod P00001· FUNDING ONLY ACTION | 2024-08-26 | +$122,587 | $1,419,819 | MEDICATION FOR PATIENT TREATMENT-RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2025-01-29 | +$4,183 | $1,424,002 | MEDICATION FOR PATIENT TREATMENT-RADIOPHARMACEUTICALS |
| Mod P00003· FUNDING ONLY ACTION | 2026-05-04 | −$2,789 | $1,421,213 | MEDICATION FOR PATIENT TREATMENT-RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CETPVZL5RQS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0409 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C24826N0693 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $111,150 | FY2026 |
| 36C25226N0456 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C26326F0080 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25726N0272 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $257,789 | FY2026 |
| 36C25726D0056 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626N0555 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $654,692 | FY2026 |
| 36C25626P0618 | HANGER PROSTHETICS & ORTHOTICS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $15,119 | FY2026 |
| 36C25626N0492 | BAYER HEALTHCARE PHARMACEUTICALS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $386,860 | FY2026 |
| 36C25626N0469 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $396,000 | FY2026 |
| 36C25626N0461 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $271,226 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25623N0893_3600_36F79720D0182_3600 · retrieved 2026-09-26.